COVID-19 疫情期间意大利伦巴第大区蛛网膜下腔出血的多中心观察研究
该多中心观察性队列研究比较了 COVID-19 疫情期(2020 年 3 月 9 日至 5 月 10 日)与疫情前三年同期在伦巴第大区 14 个中心诊断的动脉瘤性蛛网膜下腔出血(aSAH)患者。结果显示疫情期诊断延迟显著增加(1.06 天 vs 0.63 天,p=0.030),但治疗延迟无显著差异(0.89 天 vs 0.74 天,p=0.183)。疫情期预后不良(出院 GOS 1-3)比例更高(54.2% vs 40.2%,p=0.044)。
要点
- COVID-19 疫情期 aSAH 诊断延迟较疫情前增加 68%(1.06 vs 0.63 天,p=0.030)。
- 疫情期与疫情前治疗延迟无显著差异(0.89 vs 0.74 天,p=0.183)。
- 疫情期出院 GOS 1-3 比例更高(54.2% vs 40.2%,p=0.044)。
核心结论
- COVID-19 疫情暴发期间伦巴第大区 aSAH 的诊断延迟显著增加,但区域医疗重组模型避免了治疗延迟,总体结果与对照期可比。
主要发现
- COVID-19 组仅 4 例 SARS-CoV-2 阳性。
- 诊断延迟在 COVID-19 组较疫情前组显著增加 68%(1.06 vs 0.63 天,p=0.030)。
- 治疗延迟两组无显著差异(0.89 vs 0.74 天,p=0.183)。
- 出院 GOS 1-3 的患者比例在 COVID-19 期更高(54.2% vs 40.2%,p=0.044)。
- Logistic 回归中 GOS 二分结局相关变量 p<0.05 者包括入院年龄、WFNS 分级、未治疗、ICU 天数及缺血。
临床怎么用
- 疫情等医疗系统压力时期应关注 aSAH 诊断延迟,区域化集中神经外科急诊可能有助于维持治疗时效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lombardy was the most affected Italian region by the first phase of the COVID-19 pandemic and underwent urgent reorganization for the management of emergencies, including subarachnoid hemorrhage from a ruptured cerebral aneurysm (aSAH). The aim of the study was to define demographics, clinical, and therapeutic features of aSAH during the COVID-19 outbreak and compare these with a historical cohort. METHODS: In this observational multicenter cohort study, patients aged 18 years or older, who were diagnosed with aSAH at the participating centers in Lombardy from March 9 to May 10, 2020, were included (COVID-19 group). In order to minimize bias related to possible SAH seasonality, the control group was composed of patients diagnosed with aSAH from March 9 to May 10 of the three previous years, 2017-2018-2019 (pre-pandemic group). Twenty-three demographic, clinical, and therapeutic features were collected. Statistical analysis was performed. RESULTS: Seventy-two patients during the COVID-19 period and 179 in the control group were enrolled at 14 centers. Only 4 patients were positive for SARS-CoV-2. The "diagnostic delay" was significantly increased (+ 68%) in the COVID-19 group vs. pre-pandemic (1.06 vs. 0.63 days, respectively, p-value = 0.030), while "therapeutic delay" did not differ significantly between the two periods (0.89 vs. 0.74 days, p-value = 0.183). Patients with poor outcome (GOS at discharge from 1 to 3) were higher during the COVID-19 period (54.2%) compared to pre-pandemic (40.2%, p = 0.044). In logistic regression analysis, in which outcome was the dichotomized Glasgow Outcome Scale (GOS), five variables showed p-values < 0.05: age at admission, WFNS grade, treatment (none), days in ICU, and ischemia. CONCLUSIONS: We documented a significantly increased "diagnostic delay" for subarachnoid hemorrhages during the first COVID-19 outbreak in Lombardy. However, despite the dramatic situation that the healthcare system was experiencing, the Lombardy regional reorganization model, which allowed centralization of neurosurgical emergencies such as SAHs, avoided a "therapeutic delay" and led to results overall comparable to the control period.
引用
- Fiorindi A, Vezzoli M, Doglietto F, et al. Aneurismal subarachnoid hemorrhage during the COVID-19 outbreak in a Hub and Spoke system: observational multicenter cohort study in Lombardy, Italy. Acta Neurochir (Wien). 2021. PMID: 34694465. doi:10.1007/s00701-021-05013-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。